These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Treatment strategies to prevent stroke: focus on optimal lipid and blood pressure control. Papademetriou V; Doumas M Expert Opin Pharmacother; 2009 Apr; 10(6):955-66. PubMed ID: 19364247 [TBL] [Abstract][Full Text] [Related]
10. [The role of lipid metabolism in the prevention of coronary heart disease]. Mathes P; Thiery J Z Kardiol; 2005; 94 Suppl 3():III/43-55. PubMed ID: 16258792 [TBL] [Abstract][Full Text] [Related]
11. Lipids and stroke: the opportunity of lipid-lowering treatment. Vivancos-Mora J; Gil-Núñez AC Cerebrovasc Dis; 2005; 20 Suppl 2():53-67. PubMed ID: 16327254 [TBL] [Abstract][Full Text] [Related]
12. Primary prevention of coronary heart disease: where do we go from here? Gotto AM Arch Intern Med; 2001 Apr; 161(7):922-4. PubMed ID: 11295953 [No Abstract] [Full Text] [Related]
14. Niacin as a component of combination therapy for dyslipidemia. Miller M Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785 [TBL] [Abstract][Full Text] [Related]
16. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome. Fuentes B; Martínez-Sánchez P; Díez-Tejedor E Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842 [TBL] [Abstract][Full Text] [Related]
17. Clinical perspectives on primary and secondary prevention of coronary atherosclerosis. Deedwania PC Med Clin North Am; 1995 Sep; 79(5):973-98. PubMed ID: 7674695 [TBL] [Abstract][Full Text] [Related]
18. [Lipids and primary prevention of coronary disease]. Idzior-Waluś B Przegl Lek; 1998; 55(2):77-84. PubMed ID: 9695648 [TBL] [Abstract][Full Text] [Related]
19. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Brown BG; Zhao XQ; Sacco DE; Albers JJ Circulation; 1993 Jun; 87(6):1781-91. PubMed ID: 8504494 [TBL] [Abstract][Full Text] [Related]
20. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology). Esselstyn CB Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]